A phase II study of eltrombopag in the treatment of thrombocytopenia in patients with relapsed/refractory idiopathic thrombocytopenic purpura
Publication
, Journal Article
Reddy, GK; Shivakumar, L; Muneer, S; Crawford, J
Published in: Supportive Cancer Therapy
January 1, 2007
Duke Scholars
Published In
Supportive Cancer Therapy
ISSN
1543-2912
Publication Date
January 1, 2007
Volume
4
Issue
2
Start / End Page
73 / 74
Related Subject Headings
- Oncology & Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Reddy, G. K., Shivakumar, L., Muneer, S., & Crawford, J. (2007). A phase II study of eltrombopag in the treatment of thrombocytopenia in patients with relapsed/refractory idiopathic thrombocytopenic purpura. Supportive Cancer Therapy, 4(2), 73–74.
Reddy, G. K., L. Shivakumar, S. Muneer, and J. Crawford. “A phase II study of eltrombopag in the treatment of thrombocytopenia in patients with relapsed/refractory idiopathic thrombocytopenic purpura.” Supportive Cancer Therapy 4, no. 2 (January 1, 2007): 73–74.
Reddy GK, Shivakumar L, Muneer S, Crawford J. A phase II study of eltrombopag in the treatment of thrombocytopenia in patients with relapsed/refractory idiopathic thrombocytopenic purpura. Supportive Cancer Therapy. 2007 Jan 1;4(2):73–4.
Reddy, G. K., et al. “A phase II study of eltrombopag in the treatment of thrombocytopenia in patients with relapsed/refractory idiopathic thrombocytopenic purpura.” Supportive Cancer Therapy, vol. 4, no. 2, Jan. 2007, pp. 73–74.
Reddy GK, Shivakumar L, Muneer S, Crawford J. A phase II study of eltrombopag in the treatment of thrombocytopenia in patients with relapsed/refractory idiopathic thrombocytopenic purpura. Supportive Cancer Therapy. 2007 Jan 1;4(2):73–74.
Published In
Supportive Cancer Therapy
ISSN
1543-2912
Publication Date
January 1, 2007
Volume
4
Issue
2
Start / End Page
73 / 74
Related Subject Headings
- Oncology & Carcinogenesis